Ahsas Goyal, Jeetendra Kumar Gupta, Debapriya Garabadu
firstname.lastname@example.org , email@example.com
Ahsas Goyal*, Jeetendra Kumar Gupta, Debapriya Garabadu
Institute of Pharmaceutical Research, GLA University 17-Km. Stone, NH-2 Mathura - Delhi Highway, P.O. Chaumuhan, Mathura-281406 (U.P.), India.
Volume - 14,
Issue - 1,
Year - 2021
Estrogen is reported to have multi-dimensional neuroprotective activity against cognitive dysfunctions in animals and human’s despite of its classical hormonal effects. It has been well documented that postmenopausal women exhibit a higher risk of cognitive impairment than premenopausal females. In this context, estrogen replacement therapy (ERT) has been established as one of the better alternative therapy to alleviate cognitive deficits in such females. As per Women’s Health Initiative, though ERT is safe and effective strategy to mitigate cognitive dysfunction in postmenopausal ladies still it is reported to have a risk of developing breast and endometrial cancer in these women. Thus, there is a demand for developing suitable alternative medicine to conventional estrogen replacement therapy in the management of cognitive deficits. Recent phytopharmacological research suggests that phytoestrogens, naturally occurring non-steroidal compounds, from plants especially in soy and soy-based products exhibits estrogen-like physiological and pharmacological actions. Phytoestrogens primarily act through binding to estrogenic receptors (ERs) a and ß, with a higher affinity for ERß. Isoflavone phytoestrogens such as Daidzein and Genistein are widely studied herbal drugs in the management of cognitive dysfunction in postmenopausal women among other classes including lignans and coumestans. Experimental studies report that phytoestrogens exert neuroprotective activity with anti-tumor property to uterine growth. Further, clinical and in-vitro studies also corroborate the fact that phytoestrogens exhibit minimal anti-cancer activity. Epidemiological survey also documents that Asian population who consume phytoestrogen-rich diet have a lower risk of breast and prostate cancer compared to western individuals. Hence, it can be presumed that phytoestrogens could be used as a safe and alternative medicine to estrogen replacement therapy in the management of cognitive deficits in postmenopausal ladies.
Cite this article:
Ahsas Goyal, Jeetendra Kumar Gupta, Debapriya Garabadu. Phytoestrogens are emerging medicine in Prevention and Management of Cognitive deficits in Postmenopausal Women. Research J. Pharm. and Tech. 2021; 14(1):513-515. doi: 10.5958/0974-360X.2021.00093.7
Ahsas Goyal, Jeetendra Kumar Gupta, Debapriya Garabadu. Phytoestrogens are emerging medicine in Prevention and Management of Cognitive deficits in Postmenopausal Women. Research J. Pharm. and Tech. 2021; 14(1):513-515. doi: 10.5958/0974-360X.2021.00093.7 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-1-93
1. T.C. Foster, Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus.2012, 22, 656–669.
2. P.M. Maki, V.W. Henderson, Hormone therapy, dementia, and cognition: the women’s health initiative 10 years on. Climacteric. 2012, 15, 256–262.
3. C.L. Carter, E.M. Resnick, M. Mallampalli, A. Kalbarczyk, Sex and gender differences in Alzheimer’s disease: Recommendations for future research. J. Women’s Heal.2012, 21, 1018–1023.
4. J.L. Turgeon, M.C. Carr, P.M. Maki, M.E. Mendelsohn, P.M. Wise, Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr. Rev. 2006, 27, 575–605.
5. S.M. Bonomo, A.E. Rigamonti, M. Giunta, D. Galimberti, A. Guaita, M.G. Gagliano, E.E. Müller, S.G. Cella, Menopausal transition: A possible risk factor for brain pathologic events. Neurobiol. Aging. 2009, 30, 71–80.
6. S. Thomas, S. D’Almeida, Assessment of psychosocial problems and coping strategies among postmenopausal women in selected communities of mangalore. Int. J. Nur. Edu. and Research. 2014, 2(2), 173-179.
7. K. Kaur, M. Kaur, N. Raja, Nisha, R. Kaur, R. Massey, T. Jacob, Assessment of psychosocial problems and coping strategies among postmenopausal women in a selected rural and urban area at Ludhiana. Int. J. Adv. Nur. Management. 2016, 4(3), 313-326.
8. B. McEwen, Estrogen actions throughout the brain. Recent. Prog. Horm. Res.2002, 57, 357–384.
9. J.M. Daniel, J. Bohacek, The critical period hypothesis of estrogen effects on cognition: insights from basic research. Biochim. Biophys. Acta. 2010, 1800, 1068–1076.
10. X. Liu, L. Wang, D. Peng, Y. Wang, M. Ren, Effects of estrogen replacement therapy on cognitive function of ovariectomized rats. Zhonghua. Fu. Chan. Ke. Za. Zhi. 2014, 49(1), 42-47.
11. R. B. Saudagar, N. S. Dighe, D. S. Musmade, V. M. Gaware, D. A. Jain, SERM’s in treatment of breast cancer. Asian J. Pharm. Res. 2011, 1(4), 81-86.
12. A.F. Al-Anazi, V.F. Qureshi, K. Javaid, S. Qureshi, Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overview. J. Nat. Sci. Biol. Med.2011, 2(2), 154-163.
13. R.A. Hajare, K.S. Parwani, S.A. Bajad, N.A. Chandekar, A.V. Chandewar, Breastcancer and indole-3-carbinol: controversy of estrogen level and enzyme elastase. Research J. Pharm. and Tech. 2009, 2 (3), 439-440.
14. S. Soni, P. Kumar, V. S. Verma, M. Sharma, Significance of Indian medicinal plants used for treatment of dementia. Asian J. Res. Pharm. Sci. 2014, 4(4), 202-205.
15. M. Islam, J. Ramanjaneyulu, V. Babu, M. Hoque, Narayana Swamy. V.B, Studies on memory enhancing property of bravobol- A polyherbal formulation in experimentally induced alzheimers disease in experimental animals. Asian J. Res. Pharm. Sci. 2015, 5(2), 86-90.
16. K. Tripathi, Herbal memory enhancer: A review. Research Journal of Pharmacognosy and Phytochemistry. 2009, 1(2), 83-90.
17. A. S. Wanjari, D. S. Wanjari, An overview on herbal medicine. Res. J. Pharmacognosy and Phytochem. 2019, 11(1), 14-17.
18. H. V. Talele, S. B. Rathod, S. S. Pawar, A. K. Raut, A. R. Umarkar, Soyabean as a neutraceutical a phytopharmacological: Review. Research Journal of Pharmacognosy and Phytochemistry. 2012, 4(2), 112-118.
19. C. Rotem, B. Kaplan, Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: Randomized, controlled, double-blind pilot study. Gynecol. Endocrinol.2007, 23, 117–122.
20. J.D. Hirata, L.M. Swiersz, B. Zell, R. Small, B. Ettinger, Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil. Steril.1997, 68, 981–986.
21. C.B. Tempfer, G. Froese, G. Heinze, E.K. Bentz, L. A. Hefler, J.C. Huber, Side effects of phytoestrogens: A meta-analysis of randomized trials. Am. J. Med.2009, 122:939–946.
22. A. Goyal, B.C. Semwal, H.N. Yadav, Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart. Hum. Exp. Toxicol.2016, 35, 644–653.
23. J. Yamada, J. Hatabe, K. Tankyo, S. Jinno, Cell type-and region-specific enhancement of adult hippocampal neurogenesis by daidzein in middle-aged female mice. Neuropharmacology. 2016, 111, 92-106.
24. H.J. Heo, Y.M. Suh, M.J. Kim, S.J. Choi, N.S. Mun, H.K. Kim, E. Kim, C.J. Kim, H.Y. Cho, Y.J. Kim, D.H. Shin, Daidzein activates choline acetyltransferase from MC-IXC cells and improves drug-induced amnesia. Biosci. Biotechnol. Biochem. 2006,70(1), 107-111.
25. D.H. Kim, H.A. Jung, S.J. Park, J.M. Kim, S. Lee, J.S. Choi, J.H. Cheong, K.H. Ko, J.H. Ryu, The effects of daidzein and its aglycon, daidzein, on the scopolamine-induced memory impairment in male mice. Arch. Pharm. Res. 2010, 33(10), 1685-1690.
26. T. Jiang, X.Q. Wang, C. Ding, X.L. Du, Genistein attenuates isoflurane-induced neurotoxicity and improves impaired spatial learning and memory by regulating cAMP/CREB and BDNF-TrkB-PI3K/Akt signaling. Korean. J. Physiol. Pharmacol. 2017, 21(6), 579-589.
27. S. Ye, T.T. Wang, B. Cai, Y. Wang, J. Li, J.X. Zhan, G.M. Shen, Genistein protects hippocampal neurons against injury by regulating calcium/calmodulin dependent protein kinase IV protein levels in Alzheimer's disease model rats. Neural. Regen. Res.2017, 12(9), 1479-1484.
28. H.J. Lee, S.M. Lim, D.B. Ko, J.J. Jeong, Y.H. Hwang, D.H. Kim, Soyasapogenol B and genistein attenuate lipopolysaccharide-induced memory impairment in mice by the modulation of NF-κB-mediated BDNF expression. J. Agric. Food. Chem. 2017,65(32), 6877-6885.
29. M.S. Rajput, P.D. Sarkar Modulation of neuro-inflammatory condition, acetylcholinesterase and antioxidant levels by genistein attenuates diabetes associated cognitive decline in mice. Chem. Biol. Interact. 2017, 268, 93-102.
30. N.J. Mac Lusky, G. Thomas, C. Leranth, Low dietary soy isoflavonoids increase hippocampal spine synapse density in ovariectomized rats. Brain. Res. 2017, 1657, 361-367.
31. I.K. Hwang, Y.B. Lee, K.Y. Yoo, T.C. Kang, S.S. Lim, H.S. Sohn, S.M., Kim, W.J. Kim, H.K. Shin, M.H. Won, Calbindin D-28k immunoreactivity increases in the hippocampus after long-term treatment of soy isoflavones in middle-aged ovariectomized and male rats. Int. J. Neurosci. 2006, 116(8), 991-1003.
32. P. Habibi, S. Babri, N. Ahmadiasl, H. Yousefi, Effects of genistein and swimming exercise on spatial memory and expression of microRNA 132, BDNF, and IGF-1 genes in the hippocampus of ovariectomized rats. Iran. J. Basic. Med. Sci. 2017, 20(8), 856-862.
33. Arbabi, G. Hamidi, S.A. Talaei, M. Salami Estrogen agonist genistein differentially influences the cognitive and motor disorders in an ovariectomized animal model of Parkinsonism. Iran. J. Basic. Med. Sci. 2016, 19(12), 1285-1290.
34. Y.H. Huang, Q.H. Zhang, Genistein reduced the neural apoptosis in the brain of ovariectomised rats by modulating mitochondrial oxidative stress.Br. J. Nutr. 2010, 104(9), 1297-1303.